Group One Trading’s Syneron Medical Ltd ELOS Stock Holding History

Group One Trading’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,000	Closed	-$294K	–	5318
2016 Q4	$294K	Buy	+35,000	New	+$274K	﹤0.01%	2149

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Group One Trading's ELOS Position: Q1 2017 in Review

Group One Trading sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 9,870 shares — an estimated $95.5K sold.

Group One Trading first reported a position in ELOS in Q4 2013 and held it in 6 quarters. The position peaked at $83K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

Group One Trading reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
Group One Trading sold 9,870 Syneron Medical Ltd shares in Q1 2017, an estimated $95.5K.
Group One Trading first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 6 quarters.
Group One Trading's Syneron Medical Ltd position peaked at $83K in Q4 2016.
91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.